Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy
Authors:
Open Access
- 12 June 2018
- journal article
- research article
- Published by Wiley in Thoracic Cancer
- Vol. 9 (8) , 956-966
Abstract
Background: This study was conducted to investigate the correlation between clinicopathological features and post‐therapeutic response in esophageal squamous cell carcinoma (ESCC) patients. Peripheral blood circulating tumor cells (CTCs) expressing epithelial‐mesenchymal transition markers were identified.Methods: Peripheral blood samples were collected from 71 patients with newly diagnosed ESCC and 40 healthy volunteers. CTCs were isolated using CanPatrol CTC enrichment technology. RNA‐fluorescent in situ hybridization was used to phenotype the CTCs on the basis of epithelial and/or mesenchymal markers.Results: The median mesenchymal CTC counts in 71 patients were: 0 in 19 stage I patients, 2 in 31 stage II, and 3 in 21 stage III/IV. The overall diagnostic performance of total CTCs to correctly identify ESCC patients was 0.991. We observed a correlation between increases in tumor size or advanced stage and an increased number of mesenchymal CTCs (P < 0.05). Thirty‐nine patients were administered two cycles of neoadjuvant chemotherapy and their therapeutic response was evaluated: 2 complete response, 20 partial response, 13 stable disease, and 4 progressive disease. After treatment, the positive rate of mesenchymal CTCs was 70.6% in the progressive and stable disease group versus 36.4% in the complete and partial response group (P = 0.05).Conclusion: The results showed that mesenchymal CTC count is related to ESCC clinical stage and the efficacy of neoadjuvant chemotherapy.Keywords
This publication has 33 references indexed in Scilit:
- Overexpression of Snail induces epithelial–mesenchymal transition and a cancer stem cell–like phenotype in human colorectal cancer cellsCancer Medicine, 2012
- Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transitionBMC Cancer, 2012
- Gene expression profile of circulating tumor cells in breast cancer by RT-qPCRBMC Cancer, 2011
- Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patientsBreast Cancer Research, 2011
- Expression of epithelial–mesenchymal transition‐inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapyInternational Journal of Cancer, 2011
- Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patientsBreast Cancer Research, 2009
- The role of twist during palate developmentDevelopmental Dynamics, 2008
- Vimentin affects the mobility and invasiveness of prostate cancer cellsCell Biochemistry and Function, 2008
- Clinical usefulness of CYFRA 21‐1 for esophageal squamous cell carcinoma in radiation therapyJournal of Gastroenterology and Hepatology, 2007
- Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor MetastasisCell, 2004